Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00WHC
|
|||
Former ID |
DIB003333
|
|||
Drug Name |
MB-03966
|
|||
Synonyms |
AK inhibitors, Gensia; AK inhibitors, SICOR; Adenosine kinase inhibitors, Metabasis; Adenosine kinase inhibitors, SICOR; GP-3966; GP-4364; MB-03691; MB-4587; Tubercidin derivatives, Metabasis
Click to Show/Hide
|
|||
Indication | Epileptic seizures [ICD-11: 8A61-8A6Z; ICD-9: 345.9, 780.3] | Investigative | [1] | |
Company |
SICOR Inc
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adenosine kinase (ADK) | Target Info | Inhibitor | [1] |
BioCyc | Superpathway of purine nucleotide salvage | |||
Adenine and adenosine salvage II | ||||
KEGG Pathway | Purine metabolism | |||
Metabolic pathways | ||||
Reactome | Purine salvage | |||
WikiPathways | Metabolism of nucleotides |
References | Top | |||
---|---|---|---|---|
REF 1 | Engineered Adenosine-Releasing Cells for Epilepsy Therapy: Human Mesenchymal Stem Cells and Human Embryonic Stem Cells. Neurotherapeutics. 2009 April; 6(2): 278-283. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.